Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2011-12-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta15420 |
id |
doaj-16eb17f4b6834235a13e79e99f5fa2d8 |
---|---|
record_format |
Article |
spelling |
doaj-16eb17f4b6834235a13e79e99f5fa2d82020-11-25T00:15:25ZengNIHR Journals LibraryHealth Technology Assessment1366-52782011-12-01154210.3310/hta15420Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysisN Fleeman0A BagustA BolandR DicksonY DundarM MoonanJ OyeeM BlundellH DavisA ArmstrongN ThorpLiverpool Reviews and Implementation Group (LRiG), University of Liverpool, Liverpool, UKhttps://doi.org/10.3310/hta15420 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
N Fleeman A Bagust A Boland R Dickson Y Dundar M Moonan J Oyee M Blundell H Davis A Armstrong N Thorp |
spellingShingle |
N Fleeman A Bagust A Boland R Dickson Y Dundar M Moonan J Oyee M Blundell H Davis A Armstrong N Thorp Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis Health Technology Assessment |
author_facet |
N Fleeman A Bagust A Boland R Dickson Y Dundar M Moonan J Oyee M Blundell H Davis A Armstrong N Thorp |
author_sort |
N Fleeman |
title |
Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis |
title_short |
Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis |
title_full |
Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis |
title_fullStr |
Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis |
title_full_unstemmed |
Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis |
title_sort |
lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (her2): a systematic review and economic analysis |
publisher |
NIHR Journals Library |
series |
Health Technology Assessment |
issn |
1366-5278 |
publishDate |
2011-12-01 |
url |
https://doi.org/10.3310/hta15420 |
work_keys_str_mv |
AT nfleeman lapatinibandtrastuzumabincombinationwithanaromataseinhibitorforthefirstlinetreatmentofmetastatichormonereceptorpositivebreastcancerwhichoverexpresseshumanepidermalgrowthfactor2her2asystematicreviewandeconomicanalysis AT abagust lapatinibandtrastuzumabincombinationwithanaromataseinhibitorforthefirstlinetreatmentofmetastatichormonereceptorpositivebreastcancerwhichoverexpresseshumanepidermalgrowthfactor2her2asystematicreviewandeconomicanalysis AT aboland lapatinibandtrastuzumabincombinationwithanaromataseinhibitorforthefirstlinetreatmentofmetastatichormonereceptorpositivebreastcancerwhichoverexpresseshumanepidermalgrowthfactor2her2asystematicreviewandeconomicanalysis AT rdickson lapatinibandtrastuzumabincombinationwithanaromataseinhibitorforthefirstlinetreatmentofmetastatichormonereceptorpositivebreastcancerwhichoverexpresseshumanepidermalgrowthfactor2her2asystematicreviewandeconomicanalysis AT ydundar lapatinibandtrastuzumabincombinationwithanaromataseinhibitorforthefirstlinetreatmentofmetastatichormonereceptorpositivebreastcancerwhichoverexpresseshumanepidermalgrowthfactor2her2asystematicreviewandeconomicanalysis AT mmoonan lapatinibandtrastuzumabincombinationwithanaromataseinhibitorforthefirstlinetreatmentofmetastatichormonereceptorpositivebreastcancerwhichoverexpresseshumanepidermalgrowthfactor2her2asystematicreviewandeconomicanalysis AT joyee lapatinibandtrastuzumabincombinationwithanaromataseinhibitorforthefirstlinetreatmentofmetastatichormonereceptorpositivebreastcancerwhichoverexpresseshumanepidermalgrowthfactor2her2asystematicreviewandeconomicanalysis AT mblundell lapatinibandtrastuzumabincombinationwithanaromataseinhibitorforthefirstlinetreatmentofmetastatichormonereceptorpositivebreastcancerwhichoverexpresseshumanepidermalgrowthfactor2her2asystematicreviewandeconomicanalysis AT hdavis lapatinibandtrastuzumabincombinationwithanaromataseinhibitorforthefirstlinetreatmentofmetastatichormonereceptorpositivebreastcancerwhichoverexpresseshumanepidermalgrowthfactor2her2asystematicreviewandeconomicanalysis AT aarmstrong lapatinibandtrastuzumabincombinationwithanaromataseinhibitorforthefirstlinetreatmentofmetastatichormonereceptorpositivebreastcancerwhichoverexpresseshumanepidermalgrowthfactor2her2asystematicreviewandeconomicanalysis AT nthorp lapatinibandtrastuzumabincombinationwithanaromataseinhibitorforthefirstlinetreatmentofmetastatichormonereceptorpositivebreastcancerwhichoverexpresseshumanepidermalgrowthfactor2her2asystematicreviewandeconomicanalysis |
_version_ |
1725386941349756928 |